Pharmacielo Company Top Insiders
| PCLOF Stock | USD 0.06 0 4.69% |
Pharmacielo employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Pharmacielo's management performance can provide insight into the company performance.
| Andres Botero Insider Chief Officer |
| William Petron Insider Pres CEO |
Pharmacielo |
Pharmacielo Management Team Effectiveness
The company has return on total asset (ROA) of (0.2586) % which means that it has lost $0.2586 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9777) %, meaning that it generated substantial loss on money invested by shareholders. Pharmacielo's management efficiency ratios could be used to measure how well Pharmacielo manages its routine affairs as well as how well it operates its assets and liabilities.Pharmacielo Workforce Comparison
Pharmacielo is regarded third in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 42.0. Pharmacielo retains roughly 6.0 in number of employees claiming about 14% of equities under Drug Manufacturers—Specialty & Generic industry.
Pharmacielo Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharmacielo Price Series Summation is a cross summation of Pharmacielo price series and its benchmark/peer.
Pharmacielo Notable Stakeholders
A Pharmacielo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharmacielo often face trade-offs trying to please all of them. Pharmacielo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharmacielo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andres Botero | Chief Officer | Profile | |
| William Petron | Pres CEO | Profile | |
| BSc CMA | CFO Director | Profile | |
| Alex Bruvels | Co Sec | Profile | |
| Marcelo Durante | Global Devel | Profile | |
| Decio Filho | Chief Officer | Profile |
About Pharmacielo Management Performance
The success or failure of an entity such as Pharmacielo often depends on how effective the management is. Pharmacielo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharmacielo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharmacielo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. Pharmacielo is traded on OTC Exchange in the United States.
Pharmacielo Workforce Analysis
Traditionally, organizations such as Pharmacielo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharmacielo within its industry.Pharmacielo Manpower Efficiency
Return on Pharmacielo Manpower
| Revenue Per Employee | 324.2K | |
| Revenue Per Executive | 324.2K | |
| Net Loss Per Employee | 4.4M | |
| Net Loss Per Executive | 4.4M |
Complementary Tools for Pharmacielo Pink Sheet analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |